A commentary on neuronal degeneration and cell death in Guam ALS and PD: An evolutionary process of understanding

Current Alzheimer Research

Volumn 3, Issue 4, 2006, Pages 397-401

  Garruto, Ralph M ^a  

^a BINGHAMTON UNIVERSITY   (United States)

Author keywords

Gene environment interaction; Genetic susceptibility; Mitochondrial dysfunction

Indexed keywords

CELL DEATH; DEGENERATIVE DISEASE; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GUAM; HUMAN; NERVE DEGENERATION; PRIORITY JOURNAL; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL DEATH; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; GUAM; HUMANS; MITOCHONDRIAL DISEASES; NERVE DEGENERATION; NEUROTOXINS; PARKINSON DISEASE;

EID: 33748472083     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720506778249425     Document Type: Review

References (62)

1. Gadjusek DC, Zigas V. Degenerative disease of the central nervous system in New Guinea. The endemic occurrence of "kuru" in the native population. N Engl J Med 257: 974-978 (1957).
2. Gadjusek DC. Motor-neuron disease in natives of New Guinea. N Engl J Med 268: 474-476 (1963).
3. Kimura K, Yase Y, Higashi Y, Une, S, Yamamoto K, Iwasaki M, et al. Epidemiological, geomedical studies on amyotrophic lateral sclerosis. Dis Nerv Syst 24: 155-159 (1963).
4. Kurl, LT, Mulder DW. Epidemiological investigations of amyotrophic lateral sclerosis. 1. Preliminary report on geographic distributions, with special reference to the Mariana Islands, including clinical, pathological observations. Neurology 4:355-378, 438-448 (1954).
5. Shiraki H, Yase Y. Amyotrophic lateral sclerosis in Japan. In: 'Handbook of Clinical Neurology, Vol. 22'. (Eds: Vinken PJ, Bruyn GW), Elsevier Publishing Company New York, p. 353-419 (1975).
6. Garruto RM, Little MA, James GD, Brown DE. Natural experimental models: the global search for biomedical paradigms among traditional, modernizing,, modern populations. Proc Natl Acad Sci USA 96: 10536-10543 (1999).
7. Elizan TS, Hirano A, Abrams BM, Needs RL, Van Nuis C, Kurl, LT. Amyotrophic lateral sclerosis, parkinsonism-dementia complex of Guam. Neurological reevaluation. Archives of Neurology 14: 356-368 (1966).
8. Gadjusek DC, Salazar AM. Amyotrophic lateral sclerosis, parkinsonism syndromes in high incidence among the Auyu, Jakai people in West New Guinea. Neurology 32: 107-126 (1982).
9. Itoh N, Ishiguro K, Arai H, Kokubo Y, Sasaki R, Narita Y, et al. Biochemical, ultrastructural study of neurofibrillary tangles in amyotrophic lateral sclerosis/parkinsonism-dementia complex in the Kii Peninsula of Japan. J Neuropath Exper Neurol 62: 791-798 (2003).
10. Rodgers-Johnson P, Garruto RM, Gadjusek DC. Tropical myeloneuropathies - a new aetiology. Trends Neurosci 11: 526-532 (1988).
11. Hirano A, Kurl, LT, Krooth RS, Lessel S. Parkinsonism-dementia complex, an endemic disease on the isl, of Guam. I. Clinical features. Brain 84: 642-661 (1961a).
12. Hirano A, Malamud N, Kurl, LT. Parkinsonism-dementia complex, an endemic disease on the isl, of Guam. II. Pathological features. Brain 84: 662-679 (1961b).
13. Matsumoto S, Hirano A, Goto S. Spinal cord neurofibrillary tangles of Guamanian amyotrophic lateral sclerosis, parkinsonismdementia complex: An immunohistochemical study. Neurology 40: 975-979 (1990).
14. Nakai Y. Distribution of Alzheimer's neurofibrillary changes in amyotrophic lateral sclerosis. Wakayama Igaku 20: 355-370 (1969).
15. Shankar SK, Yanagihara R, Garruto RM, Grundke-Iqbal I, Kosik KS, Gadjusek DC. Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis, parkinsonismdementia on Guam. Ann Neurol 25: 146-151 (1989).
16. Arnold A, Edgren DC, Palladino VS. Amyotrophic lateral sclerosis: Fifty cases observed on Guam. J Nerv Ment Dis 177: 135-139 (1953).
17. Hirano A. Progress in the pathology of motor neuron diseases. In: 'Progress in Neuropathology, Vol. II'. (Ed: Zimmerman HM), Grune, Stratton New York, p. 181-215 (1973).
18. Gibbs CJ Jr, Gadusek DC. An update on long-term in vivi, in vitro studies designed to identify a virus as a cause of amyotropihc lateral sclerosis, parkinsonism-dementia, Parkinson disease. In: 'Advances in Neurology, Vol. 36, Human Motor Neuron Disease'. (Ed: Rowl, LP), Raven Press New York, p. 343-353 (1982).
19. Whiting MG. Food practices in ALS foci in Japan, the Marianas, New Guinea. Fed Proc 23: 1343-1345 (1964).
20. Yase Y. The pathogenesis of amyotrophic lateral sclerosis. Lancet 2: 292-296 (1972).
21. Garruto RM. Pacific paradigms of environmentally induced neurological disorders: clinical, epidemiological, molecular perspectives. NeuroToxicology 12: 12347-12378 (1991).
22. Garruto RM, Yanagihara R, Gajdusek DC. Disappearance of high incidence amyotrophic lateral sclerosis, parkinsonism-dementia on Guam. Neurology 35: 193-198 (1985a).
23. Duncan MW, Kopin IJ, Garruto RM, Lavine L, Markey SP. 2-amino-3 (methylamino)-propionic acid in cycad-derived foods is an unlikely cause of amyotrophic lateral sclerosis/parkinsonism. Lancet 2: 631-632 (1988).
24. Duncan MW, Steele JC, Kopin IJ, Markey SP. 2-amino-3 (methylamino)- propanoic acid (BMAA) in cycad flour: An unlikely cause of amyotrophic lateral sclerosis, parkinsonism dementia of Guam. Neurology 40: 767-772 (1990).
25. Garruto RM, Fukatsu R, Yanagihara R, Gajdusek DC, Hook G, Fiori CE. Imaging of calcium, aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. PNAS 81: 1875-1879 (1984).
26. Garruto RM, Swyt C, Fiori CE, Yanagihara R, Gajdusek DC. Intraneuronal deposition of calcium, aluminium in amyotrophic lateral sclerosis of Guam. Lancet 326: 1353 (1985b).
27. Perl DP, Gajdusek DC, Garruto RM, Yanigahara RT, Gibbs CJ Jr. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis, parkinsonism-dementia of Guam. Science 217: 1053-1055 (1982).
28. Spencer PS, Nunn PB, Hugon J, Ludopth AC, Ross SM, Roy DN, et al. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to plant exicitant neurotoxin. Science 237: 517-522 (1987).
29. Spencer PS, Allen RG, Kisby GE, Ludolph AC. Excitotoxic disorders. Science 248: 144 (1990).
30. Traub RD, Rains TC, Garruto RM, Gajdusek DC, Gibbs CJ Jr. Brain destruction alone does not elevate brain aluminum. Neurology 31: 986-990 (1981).
31. Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, et al. ALS, PDC of Guam. Forty-year follow-up. Neurology 58: 765-773 (2002).
32. Garruto RM, Yase Y. Neurodegenerative disorders of the western Pacific: the search for mechanisms of pathogenesis. Trends Neurosci 9: 368-374 (1986).
33. Yanagihara R, Garruto, RM, Gajdusek DC, Tomita A, Uchikawa T, Konagaya Y, et al. Calcium, vitamin D metabolism in Guamanian Chamorros with amyotrophic lateral sclerosis, parkinsonism-dementia. Ann Neurol 15: 42-48 (1984).
34. Cox PA, Sacks OW. Cycad neurotoxins, consumption of flying foxes,, ALS-PCD disease in Guam. Neurology 58: 956-959 (2002).
35. Murch SJ, Cox PA, Banack SA, Steele JC, Sacks OW. Occurrence of B-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol Scand 110: 267-269 (2004).
36. Dastur DK, Palekar RS. The experimental pathology of cycad toxicity with special reference to oncogenic effects. Ind J Cancer March: 33-49 (1974).
37. Esclaire F, Kisby G, Spencer, P, Milne J, Lesort M, Hugon J. The Guam cycad toxin methylazoxymethanol damages neuronal DNA, modulated Tua mRNA expression, excitotoxicity. Exp Neurol 155: 11-21 (1999).
38. Kisby GE, Roy DN, Spencer PS. Determination of B-N-methylamino-L-alanine (BMAA) in plant (Cycas circinalis L.), animal tissue by precolumn dramatization with 9-fluorenylmethyl chloroformate (FMOC), reversed-phase high-performance liquid chromotography. J Neurosci Methods 26: 45-54 (1988).
39. Strong MJ, Garruto RM. Neuron-specific thresholds of aluminum toxicity in vitro: a comparative analysis of dissociated fetal rabbit hippocampal, motor neuron-enriched cultures. Laboratory Investigation 66: 243-249 (1991).
40. Strong MJ, Wolff AV, Wakayama I, Garruto RM. Aluminuminduced chronic myelopathy in rabbit. Neurotoxicology 12: 9-22 (1991).
41. Strong MJ, Mao K, Nerurkar VR, Wakayama I, Yanagihara R, Garruto RM. Dose-dependent selective supression of light (NFL), medium (NFM) but not heavy (NFH) molecular weight neurofilament mRNA levels in acute aluminum neurotoxicity. Molecular, Cellular Neurosciences 5: 319-326 (1994).
42. Wakayama I, Nerurkar VR, Garruto RM. Immunocytochemical, ultrastructural evidence of dendritic degeneration in motor neurons of aluminum intoxicated rabbits. Acta Neuropathol 85: 122-128 (1993).
43. Wakayama I, Nerurkar VR, Strong MJ, Garruto RM. Comparative study of chronic aluminum-induced neurofilamentous aggregates with intracytoplasmic inclusions of amyotrophic lateral sclerosis. Acta Neuropathol 92: 545-554 (1996).
44. Wakayama I, Song K-J, Nerurkar VR, Yoshida S, Garruto RM. Slow dendritic transport of dissociated mouse hippocampal neurons exposed to aluminum. Brain Research 748: 237-240 (1997).
45. Yasui M, Ota K, Garruto RM. Effects of calcium-deficient diets on manganese deposition in the central nervous system, bones of rats. Abstracts of the 10th International Neurotoxicology Conference, Little Rock, Arkansas, September 28-October 1, 1992. Neurotoxicology 16: 511-517 (1995).
46. Plato CC, Reed DM, Elizan TS, Kurl, LT. Amyotrophic lateral sclerosis/parkinsonism dementia complex of Guam. IV. Familial, genetic investigations. Am J Hum Gen 19: 617-632 (1967).
47. Plato CC, Cruz MT, Kurl, LT. Amyotrophic lateral sclerosis/parkinsonism- dementia complex of Guam: Further genetic investigations. Am J Hum Genet 21: 133-141 (1969).
48. Plato CC, Garruto RM, Fox KM, Gadjusek DC. Amyotrophic lateral sclerosis, parkinsonism-dementia complex of Guam: A 25-year prospective case-control study. Am J Epidemiol 124: 643-656 (1986).
49. Plato CC, Garruto RM, Galasko D, Craig UK, Plato M, Gamst A, et al. Amyotrophic lateral sclerosis, parkinsonism-dementia complex of Guam: Changing incidence rates during the past 60 years. Am J Epidemiol 157:149-157 (2003).
50. Figlewicz DA, Garruto RM Krizus A, Yanagihara R, Rouleau GA. The Cu/ZN superoxide dismutase gene in ALS and Parkinsonism-dementia complex of Guam. NeuroReport 5: 557, 560 (1994).
51. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43: 815-825 (1998).
52. Bailey-Wilson JE, Plato CC, Elston RC, Garruto RM. Potential role of an addictive genetic component in the cause of amyotrophic lateral sclerosis, parkinsonism-dementia in the Western Pacific. Am J Med Gen 45: 68-86 (1993).
53. Garruto RM. Disease patterns of isolated groups. In: 'Biocultural assessment of the genetic relationships of Native American Populations'. (Ed: Rothschild HR), p. 557-597. Academic Press, New York (1981).
54. Carri MT, Ferri A, Cozzolino M, Calabrese L, Rotilio G. Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress, altered homeostasis of metals. Brain Reseach Bulletin 61: 365-374 (2003).
55. Emerit J, Edeas M, Bricaire F. Neurodegenerative disease, oxidative stress. Biomed Pharmacotherapy 58: 39-46 (2004).
56. Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius S. Role of Mitochondria in Toxic Oxidative Stress. Mol Interv 5: 94-111 (2005).
57. Simonian NA, Coyle JT. Oxidative Stress in Neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36: 83-106 (1996).
58. Coskun PE, Beal MF, Wallace DC. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription, replication. PNAS 101: 10726-10731 (2004).
59. Gaspari M, Falkenberg M, Larsson N-G, Gustafsson CM. The mitochondrial RNA polymerase contributes critically to promotor specificity in mammalian cells. EMBO 23: 4606-4614 (2004).
60. Gulbins E, Dreschers S, Bock J. Role of mitochondria in apoptosis. Exp Physiol 88: 85-90 (2003).
61. Von Kleist-Retzow J-C, Schauseil-Zipf U, Michalk DV, Kunz WS. Mitochondrial diseases - an expanding spectrum of disorders, affected genes. Exp Physiol 88: 155-166 (2003).
62. Hermosura MC, Nayakanti H, Dorovkov MV, Calderon FR, Ryazanov AG, Haymer DS, et al. A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders. PNAS 102: 11510-11515 (2005).